Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-28

FDA Approved: POMALIDOMIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for pomalidomide by Aurobindo Pharma Limited under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomalidomide (Pomalidomide)

Snippet

SUPPL AP for POMALIDOMIDE (POMALIDOMIDE)